Blackford Gary - Aug 13, 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Director
Signature
/s/ Mojirade James, as attorney-in-fact for Gary D. Blackford
Stock symbol
AVNS
Transactions as of
Aug 13, 2025
Transactions value $
$659,300
Form type
4
Date filed
8/15/2025, 12:02 PM
Previous filing
Jan 6, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BLACKFORD GARY Director 5405 WINDWARD PARKWAY, ALPHARETTA /s/ Mojirade James, as attorney-in-fact for Gary D. Blackford 2025-08-15 0001156320

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Purchase $220K +20K +27.94% $10.98 91.6K Aug 13, 2025 Direct F1
transaction AVNS Common Stock Purchase $440K +40K $11.00 40K Aug 13, 2025 Shares held in trust. F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.94 to $11.01, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.98 to $11.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 These shares are held in trusts for the benefit of certain immediate family members of the Reporting Person. The Reporting Person is co-trustee of such trusts. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.